Home/Compounds/Pharmaceutical Intermediate/(S)-3,3-DIMETHYL-2-(2,2,2-TRIFLUOROACETAMIDO)BUTANOIC ACID
C8H12F3NO3
227.18 g/mol
Pharmaceutical IntermediateWarning
(S)-3,3-DIMETHYL-2-(2,2,2-TRIFLUOROACETAMIDO)BUTANOIC ACID
CAS666832-71-9EC871-918-4
Category
Pharmaceutical Intermediate
Compound Class
Amide
Primary Use
Pharmaceutical Intermediate
This compound is a chiral amino acid derivative featuring a trifluoroacetyl protective group and a tert-butyl side chain. It is primarily used as a pharmaceutical intermediate in research and manufacturing settings.
Pharmaceutical intermediate for peptide synthesisLaboratory research reagent
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing (S)-3,3-DIMETHYL-2-(2,2,2-TRIFLUOROACETAMIDO)BUTANOIC ACID?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Related Compounds
ReferenceSame Category
2,3,5-Trifluoronitrobenzene
CAS66684-57-9
pharmaceutical intermediate
ReferenceSame Category
2,3-Difluoro-6-nitroanisole
CAS66684-60-4
pharmaceutical intermediate
ReferenceSame Category
[[4-[[2-(1-Methylethoxy)ethoxy]methyl]phenoxy]methyl]oxirane
CAS66722-57-4
pharmaceutical intermediate
ReferenceSame Category
N-(2,5-Dichlorobenzoyl)glycine
CAS667403-46-5
pharmaceutical intermediate
Safety Reference
Warning
H302Harmful if swallowed
H312Harmful in contact with skin
H332Harmful if inhaled
H373May cause damage to organs through prolonged or repeated exposure
Identifiers
IUPAC Name
(2S)-3,3-dimethyl-2-[(2,2,2-trifluoroacetyl)amino]butanoic acid
InChIKey
FCTPLAZWXGEGKO-SCSAIBSYSA-N
SMILES
CC(C)(C)[C@@H](C(=O)O)NC(=O)C(F)(F)F
Synonyms (10)
- Nirmatrelvir Impurity 23
- n-trifluoroacetyltert-leucine
Sourcing (S)-3,3-DIMETHYL-2-(2,2,2-TRIFLUOROACETAMIDO)BUTANOIC ACID?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.